COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU

Patients hospitalized in the intensive care unit (ICU) due to the COVID-19 experience a high incidence (up to 43%) of venous thromboembolic events. While laboratory findings in COVID-19-associated coagulopathy (CAC) show increased D-dimer and fibrinogen levels, the abnormalities in standard coagulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pluta, Jan, Trzebicki, Agnieszka Cieniewicz Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158437/
https://www.ncbi.nlm.nih.gov/pubmed/34006056
http://dx.doi.org/10.5114/ait.2021.105783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158437/
https://www.ncbi.nlm.nih.gov/pubmed/34006056
http://dx.doi.org/10.5114/ait.2021.105783

Ejemplares similares